Arena Pharmaceuticals (ARNA) Stock: Here’s What You Need To Know

Arena Pharmaceuticals (NASDAQ:ARNA) Arena Pharmaceuticals has been struggling to stay afloat as a company, especially with Belviq under performing in the obesity market. Thing are about to get worse because now it will have to go back to the drawing board. In other words, it has admitted that Belviq is not taking off in the … Read more

Biotech Stock News (ARNA) (BMRN) (SRPT)

Arena Pharmaceuticals (NASDAQ:ARNA) On Tuesday January 12, 2016 Arena Pharmaceuticals announced a collaboration with a privately held pharmaceuticals company, known as Boehringer Ingelheim — BI. This research collaboration is an early one targeting G-coupled protein receptors. These types of protein receptors go after several types of Central Nervous System — CNS — disorders. Arena is … Read more

Biotech Stock News (SYN) (ZFGN) (ARNA) (OREX) (VVUS)

Synthetic Biologics (NYSE:SYN) On Thursday December 3, 2015 Synthetic Biologics announced positive phase 2 results for the prevention of a bacterial infection known as C. difficile. The drug the company is using to combat against this bacterial infection is known as SYN-004. This drug was created for the purpose of clearing out IV fluid, such … Read more